|
WO2020164603A1
|
|
Fgfr inhibitor compound in solid form and preparation method therefor
|
|
WO2020156017A1
|
|
Targeted ubiquitination degradation brd4 protein compound, preparation method therefor and application thereof
|
|
CN111170879A
|
|
Small-particle-size pregabalin and preparation method thereof
|
|
CN111116572A
|
|
Oxadiazole derivatives, their preparation and use
|
|
WO2017054765A1
|
|
Benzamide derivative
|
|
CN106928149A
|
|
A kind of preparation method of olaparib
|
|
CN106667926A
|
|
Favipiravir tablets and preparation method thereof
|
|
CN105384739A
|
|
Pyrazolo[3,4-c]pyridine derivative
|
|
CN105985394A
|
|
Novel sofosbuvir crystal form and preparation method thereof
|
|
CN105982108A
|
|
Carrot juice drink and preparation method thereof
|
|
CN105820157A
|
|
Vilazodone hydrochloride crystal form and preparation method thereof
|
|
CN105368860A
|
|
Recombinant plasmid carrier and construction method and application thereof
|
|
CN105456270A
|
|
Dipeptidyl peptidase IV inhibitor pharmaceutical composition, use and preparation method thereof
|
|
CN105832740A
|
|
Aromatic amino purine derivative as well as preparation method and pharmaceutical application thereof
|
|
EP1757286A1
|
|
The application of l-n-butylphthalide in preventing and treating alzheimer's disease
|
